Theyre especially popular among patients undergoing facial rejuvenation procedures, helping to support recovery, immune function, and overall vitality
8 BPC-157 + TB-500 Case Series (PubMed)Small, low-quality case series of combined BPC-157 and TB-500 for joint injury at higher, intra-articular doses
Compounded medications are legal under Section 503A of the Federal Food, Drug, and Cosmetic Act when: A licensed provider writes a patient-specific prescription The medication is prepared by a licensed compounding pharmacy The medication is not a copy of a commercially available product, OR the commercial product is on the FDA drug shortage list As of April 2026, tirzepatide remains on the FDA drug shortage list (added December 2022, extended through Q2 2026), which allows compounding pharmacies to prepare tirzepatide formulations legally
At first, I didnt have high hopes, But its been less than two weeks., I was really surprised